1228095-06-4

Basic information

• Product Name: Methyl 2-benzyloxy-4-bromobenzoate
• Synonyms: Methyl 2-benzyloxy-4-bromobenzoate
• CAS NO: 1228095-06-4
• Molecular Formula: C15H13BrO3
• Molecular Weight: 321.16592
• Mol File: 1228095-06-4.mol

Chemical Properties

• Appearance: /
• Storage Temp.: Room temperature.
• CAS DataBase Reference: Methyl 2-benzyloxy-4-bromobenzoate(CAS DataBase Reference)
• NIST Chemistry Reference: Methyl 2-benzyloxy-4-bromobenzoate(1228095-06-4)
• EPA Substance Registry System: Methyl 2-benzyloxy-4-bromobenzoate(1228095-06-4)

Safety Data

• Hazardous Substances Data: 1228095-06-4(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Research:
Methyl 2-benzyloxy-4-bromobenzoate is utilized as an intermediate in the synthesis of pharmaceuticals for its ability to be modified and incorporated into complex molecular structures. Its presence in drug development can contribute to the creation of new medications with specific therapeutic effects.
Used in Agrochemical Production:
In the agrochemical industry, Methyl 2-benzyloxy-4-bromobenzoate is employed as a key component in the formulation of various agrochemicals. Its chemical properties allow it to be a part of compounds that can be used in pest control and crop protection, enhancing agricultural productivity.
Used in Material Science:
Methyl 2-benzyloxy-4-bromobenzoate is used as a building block in the development of new materials. Its unique structure and reactivity make it suitable for the creation of advanced materials with specific properties required in various industries.
Used in Dye Manufacturing:
In the dye industry, Methyl 2-benzyloxy-4-bromobenzoate is used as a precursor in the production of dyes. Its chemical composition contributes to the color and stability of the dyes, which are then used in textiles, printing, and other applications.
Used in Organic Synthesis:
As a versatile organic compound, Methyl 2-benzyloxy-4-bromobenzoate is used as a reagent in organic synthesis. It serves as a starting material for the preparation of other organic compounds, contributing to the advancement of organic chemistry and the discovery of new chemical entities.

Upstream product

• 22717-56-2 4-bromo-2-Hydroxybenzoic Acid Methylester 
• 100-39-0 benzyl bromide 
• 1666-28-0 4-bromosalicylic acid 

Downstream Products

• 861533-46-2 4-(4-carboxy-3-hydroxy-phenyl)-2-hydroxy-benzoic acid 
• 1382735-24-1 3-mer-HCA 

Relevant articles and documents

Development of DHQ-based chemical biology probe to profile cellular targets for HBV

Chronic hepatitis B virus (HBV) infection has been a serious public health burden worldwide. Current anti-HBV therapies could not eliminate HBV ultimately. Considering the characteristics of HBV, it is impossible to be entirely cured based on current therapies. Therefore, it is urgently needed to develop novel therapeutic agents with new mechanism of action. The dihydroquinolizinone (DHQ) derivatives exhibited potent anti-HBV activity by decreasing HBV DNA and HBsAg level in an obscure mechanism of action. In this study, we have optimized the DHQ scaffold, developed the photoaffinity probe, with which to identify potential binding proteins.

Temperature-Controlled Evolution of Nanoporous MOF Crystallites into Hierarchically Porous Superstructures

Sophisticated multichannel tubular structures have long been utilized in biological systems. However, the well-controlled assembly of biomimetic materials utilizing these features still remains a challenge. Herein, we report an unexpected one-pot fabrication of biomimetic hierarchically porous metal-organic framework (MOF) tubular superstructures. This temperature-controlled structural evolution was investigated under solvothermal conditions: crystalline hollow MOF tubes can be obtained via self-templating and self-healing at higher temperatures, whereas hierarchical helical or multichannel tubular superstructures are fabricated through a helical or oriented evolution process at lower temperatures. Our work here presents the first example of tubular MOF superstructures and highlights the unexpected power of self-assembly and healing during structural evolution process. It has been widely observed in various scales that complex systems have a hierarchical or multilevel organization. For instance, hierarchical tubular structures are commonly adopted in natural systems, including bears and bamboo, as a result of long-term evolution, which can help enhance fluid transportation in plants, reduce the overall weight of animals, and prevent heat transfer. Our discovery here mimics the natural evolution and generates a series of hierarchically porous metal-organic framework (MOF) superstructures through self-templating, self-healing, and oriented evolution. This facile strategy provides fresh insights into MOF growth and oriented evolution mechanisms, enabling the state-of-the-art design of multichannel materials with promising applications in water harvesting and transport, multicomponent drug delivery, efficient catalysis, and fabrication of multichannel carbon rods for energy storage. Hierarchically porous superstructures have been successfully assembled from nanoporous MOF crystallites. Benefiting from the dynamic coordination bond formation, hierarchical helical or multichannel tubular superstructures can be accessed through oriented assembly of MOF crystallites. This temperature-controlled structural evolution also enables the formation of crystalline hollow MOF tubes via self-templating and self-healing processes. Further incorporation of multiple components into these frameworks provides a fresh route for preparing stable, multivariate, and hierarchical frameworks with accessible catalytically active sites for heterogeneous catalysis.

SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

This invention relates to 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid (benzyl-cyano-methyl)- amides of formula (1) and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases.

SUBSTITUTED 2-AZA-BICYCLO[2.2.1]HEPTANE-3-CARBOXYLIC ACID (BENZYL-CYANO-METHYL)-AMIDES INHIBITORS OF CATHEPSIN C

This invention relates to 2-Aza-bicyclo[2.2.1]heptane-3-carboxylic acid(benzyl-cyano-methyl)-amides of formula 1 and their use as inhibitors of Cathepsin C, pharmaceutical compositions containing the same, and methods of using the same as agents for treatment and/or prevention of diseases connected with dipeptidyl peptidase I activity, e.g. respiratory diseases.